BRIEF published on 04/30/2024 at 13:05, 1 year 7 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
BRIEF published on 04/30/2024 at 13:05, 1 year 7 months ago Emmecell achève le dosage final de la thérapie cellulaire dans le cadre d'un essai clinique américain sur l'œdème cornéen Thérapie Cellulaire Essai Clinique Emmecell Œdème Cornéen Traitement Non Chirurgical
PRESS RELEASE published on 04/30/2024 at 13:00, 1 year 7 months ago Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
Published on 12/17/2025 at 23:15, 26 minutes ago Northern Superior Announces the Ratio for the Distribution of the Common Shares in the Capital of ONGold Resources Ltd.
Published on 12/17/2025 at 15:00, 8 hours 41 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 9 hours 41 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 10 hours 6 minutes ago Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 10 hours 26 minutes ago Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 22:05, 1 hour 36 minutes ago Abivax annonce l’acceptation de 22 abstracts sur obefazimod dans les MICI à l’ECCO 2026, dont une présentation orale sur des résultats précliniques antifibrotiques
Published on 12/17/2025 at 22:05, 1 hour 36 minutes ago Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Published on 12/17/2025 at 21:22, 2 hours 19 minutes ago EQS-Adhoc: DATAGROUP SE: DATAGROUP SE Management Board plans dividend of EUR 0.04 per share
Published on 12/17/2025 at 20:12, 3 hours 29 minutes ago EQS-Adhoc: Rheinmetall AG: Executive Board decides to sell activities of the civil division Power Systems – Target is sale in the first quarter of 2026; update of outlook for continuing operation
Published on 12/17/2025 at 19:39, 4 hours 1 minute ago Avolta awarded Shanghai Pudong International Airport concession, marking a first-in-a-generation duty-free win for an international operator in mainland China
Published on 12/17/2025 at 20:39, 3 hours 2 minutes ago Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 20:39, 3 hours 2 minutes ago Aeroports de Paris SA | Tarifs des redevances aeroportuaires 2026 à Paris
Published on 12/17/2025 at 19:30, 4 hours 11 minutes ago Evolution de la composition du Conseil d’Administration
Published on 12/17/2025 at 18:00, 5 hours 41 minutes ago Outstanding Shares and Voting Rights Statement at 30 November 2025
